Drug profile · INN
fluticasone furoate + umeclidinium + vilanterol
TRELEGY ELLIPTA 100/62.5/25
- Patents linked
- 0
- News articles
- 0
Quick answer
fluticasone furoate + umeclidinium + vilanterol (TRELEGY ELLIPTA 100/62.5/25) is an FDA-listed pharmaceutical active ingredient. Associated with GlaxoSmithKline.
Key facts
INN fluticasone furoate + umeclidinium + vilanterol
Brand TRELEGY ELLIPTA 100/62.5/25
Originator GlaxoSmithKline
Frequently asked questions
What is fluticasone furoate + umeclidinium + vilanterol?
fluticasone furoate + umeclidinium + vilanterol (TRELEGY ELLIPTA 100/62.5/25) is an FDA-listed pharmaceutical active ingredient. Associated with GlaxoSmithKline.
What is the brand name for fluticasone furoate + umeclidinium + vilanterol?
TRELEGY ELLIPTA 100/62.5/25 is a marketed brand name for fluticasone furoate + umeclidinium + vilanterol. Check FDA Drugs@FDA for the current US label holder and prescribing information.